当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Husam Bader , Olaedo Abana, Rama Maghnam , Husam Farraj and Rabih Bechara
Introduction: Sarcoidosis is a common, often multi systemic idiopathic chronic inflammatory disease diagnosed histologically by findings of epithelioid non caseating granulomas. While Fluorodeoxyglucose FDG-avid lymph nodes on Positron Emission Tomography (PET) scan in a patient with histologically confirmed malignancy should raise suspicion for nodal metastases, sarcoidosis is a known cause of benign Fluorodeoxyglucose FDG-avidity in cancer patients and must be ruled out to avoid unjustified treatment and potential toxicities. Methods: A single-center retrospective study involving 46 female patients with breast cancer was conducted. Patients included in the study had been found to have new FDG-avid mediastinal and hilar lymphadenopathy on Positron Emission Tomography (PET) scan and had undergone Endobronchial ultrasound (EBUS) / Endoscopic ultrasound (EUS) with TBNA (Trans-Bronchial Needle Aspiration). Results: Of the 46 patients in the study, 31 patients (67.4%) were found to have lymph node metastases, noncaseating granulomas consistent with sarcoid-like reactions were found in 3 patients (6.5%), and negative exam (neither sarcoid-like reactions nor nodal metastases) was found in 12 patients (26.10%). Conclusion: Pathological examination of hyper metabolic nodes must be carried out in cancer patients with PET scan findings concerning for lymph node metastases to prevent misdiagnosis and overtreatment.